Yubo International Biotech Ltd financial data

Symbol
YBGJ on OTC
Location
Room 105, Building 5, 31 Xishiku Avenue, Beijing, China
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 15.7 % -18.3%
Quick Ratio 0.88 % -74.2%
Debt-to-equity -135 % +19.1%
Return On Equity 46.2 % -47.1%
Return On Assets -122 % +1.72%
Operating Margin 7.69M %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 170M shares +42.2%
Entity Public Float 43.4K USD
Weighted Average Number of Shares Outstanding, Diluted 148M shares +23.4%

Income Statement

Label TTM Value / Value Unit Change %
Revenues -18 USD -100%
Operating Income (Loss) -1.38M USD +28.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -1.38M USD +35.7%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -1.43M USD +29.9%
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 10.9K USD +36%
Inventory, Net 37.9K USD +476%
Assets, Current 650K USD -10.3%
Property, Plant and Equipment, Net 84.6K USD -67%
Operating Lease, Right-of-Use Asset 139K USD -76.1%
Intangible Assets, Net (Excluding Goodwill) 43.2K USD -22.9%
Assets 953K USD -42.4%
Liabilities, Current 2.56M USD -43.1%
Operating Lease, Liability, Noncurrent 0 USD -100%
Liabilities 2.56M USD -45.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax 176K USD +34.1%
Retained Earnings (Accumulated Deficit) -7.48M USD -17.4%
Stockholders' Equity Attributable to Parent -1.66M USD +46.9%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -1.6M USD +47.3%
Liabilities and Equity 953K USD -42.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -392K USD -18.6%
Net Cash Provided by (Used in) Financing Activities 278K USD -9.87%
Net Cash Provided by (Used in) Investing Activities -6.19K USD +79.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 2.76K USD -94.6%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 10.9K USD +36%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 2.13M USD +47%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.17 pure 0%
Operating Lease, Liability 139K USD -76.1%
Payments to Acquire Property, Plant, and Equipment 6.19K USD -67.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -1.33M USD +40.7%
Lessee, Operating Lease, Liability, to be Paid 158K USD -74.5%
Property, Plant and Equipment, Gross 153K USD -45.2%
Operating Lease, Liability, Current 139K USD -62.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 110K USD +92.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 79.7K USD -79.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 79.7K USD
Deferred Tax Assets, Operating Loss Carryforwards 1.45M USD
Preferred Stock, Shares Issued 0 shares
Current Income Tax Expense (Benefit) -467K USD -356%
Preferred Stock, Shares Authorized 5M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 17K USD
Additional Paid in Capital 5.51M USD +84.5%
Amortization of Intangible Assets 11.7K USD -12.3%
Depreciation, Depletion and Amortization 164K USD -32.4%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Interest Expense 18K USD +36635%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%